AUTL
Autolus Therapeutics
AUTL
AUTL
121 hedge funds and large institutions have $1.12B invested in Autolus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
50% more capital invested
Capital invested by funds: $747M → $1.12B (+$374M)
22% more funds holding
Funds holding: 99 → 121 (+22)
0.57% less ownership
Funds ownership: 66.67% → 66.1% (-0.57%)
Holders
121
Holding in Top 10
5
Calls
$1.19M
Puts
$625K
Top Buyers
| 1 | +$77M | |
| 2 | +$67.1M | |
| 3 | +$56.2M | |
| 4 |
DM
Deerfield Management
New York
|
+$22.7M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$21.2M |
Top Sellers
| 1 | -$38.6M | |
| 2 | -$3.9M | |
| 3 | -$2.96M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$2.92M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.39M |